[Clinico-pathological investigation of radiation therapy for brain tumors].
Ozaki
Yoshimaru
Y
Laboratory of Molecular & Cellular Pathology, Hokkaido University Graduate School of Medicine, Sapporo 060-8638, Japan.
D000328:Adult; D000368:Aged; D015703:Antigens, CD / Q000032:analysis; D018952:Antigens, CD34 / Q000032:analysis; D015214:Antigens, Differentiation, Myelomonocytic / Q000032:analysis; D001932:Brain Neoplasms / Q000235:genetics / Q000473:pathology* / Q000532:radiotherapy* / Q000556:secondary; D005260:Female; D016158:Genes, p53 / Q000235:genetics; D005910:Glioma / Q000235:genetics / Q000473:pathology* / Q000532:radiotherapy*; D006801:Humans; D007150:Immunohistochemistry; D008279:Magnetic Resonance Imaging; D008297:Male; D008875:Middle Aged; D009154:Mutation; D009364:Neoplasm Recurrence, Local / Q000473:pathology; D009442:Neurilemmoma / Q000235:genetics / Q000473:pathology* / Q000532:radiotherapy*; D013997:Time Factors; D016159:Tumor Suppressor Protein p53 / Q000032:analysis; D000097382:CD68 Molecule
D015703:Antigens, CD; D018952:Antigens, CD34; D015214:Antigens, Differentiation, Myelomonocytic; D016159:Tumor Suppressor Protein p53; C067980:CD68 antigen, human; D000097382:CD68 Molecule